These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study. Weiss K; Buxton M; Andersson FL; Lamm CJ; Liljas B; Sullivan SD Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():21-7. PubMed ID: 16573705 [TBL] [Abstract][Full Text] [Related]
27. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Edmonds ML; Camargo CA; Pollack CV; Rowe BH Cochrane Database Syst Rev; 2003; (3):CD002308. PubMed ID: 12917930 [TBL] [Abstract][Full Text] [Related]
28. Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial. De Vera MA; Sadatsafavi M; Tsao NW; Lynd LD; Lester R; Gastonguay L; Galo J; FitzGerald JM; Brasher P; Marra CA Trials; 2014 Dec; 15():488. PubMed ID: 25494702 [TBL] [Abstract][Full Text] [Related]
29. Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities. O'Connor RD; Parasuraman B; Roberts C; Leibman C Ann Allergy Asthma Immunol; 2006 Aug; 97(2):236-43. PubMed ID: 16937758 [TBL] [Abstract][Full Text] [Related]
30. Impact of omalizumab on medical cost of childhood asthma in Japan. Yoshikawa H; Iwata M; Matsuzaki H; Ono R; Murakami Y; Taba N; Honjo S; Motomura C; Odajima H Pediatr Int; 2016 May; 58(5):425-8. PubMed ID: 27173421 [TBL] [Abstract][Full Text] [Related]
31. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208 [TBL] [Abstract][Full Text] [Related]
32. A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II). Sullivan SD; Lee TA; Blough DK; Finkelstein JA; Lozano P; Inui TS; Fuhlbrigge AL; Carey VJ; Wagner E; Weiss KB Arch Pediatr Adolesc Med; 2005 May; 159(5):428-34. PubMed ID: 15867115 [TBL] [Abstract][Full Text] [Related]
33. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population. Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006 [TBL] [Abstract][Full Text] [Related]
34. Inhaled corticosteroid use and asthma hospitalization rates in Japan. Odajima Y; Kuwabara H J Int Med Res; 2006; 34(2):208-14. PubMed ID: 16749417 [TBL] [Abstract][Full Text] [Related]
35. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma. O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013 [TBL] [Abstract][Full Text] [Related]
36. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs. Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831 [TBL] [Abstract][Full Text] [Related]
37. Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990-1999). Neffen H; Baena-Cagnani C; Passalacqua G; Canonica GW; Rocco D Respir Med; 2006 Aug; 100(8):1431-5. PubMed ID: 16364622 [TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of asthma controller therapies: influence of disease severity and other variables. Navarro RP; Parasuraman B Manag Care Interface; 2005 Jun; 18(6):31-40. PubMed ID: 16018297 [TBL] [Abstract][Full Text] [Related]
39. Cost-utility analysis of the inhaled steroids available in a developing country for the management of pediatric patients with persistent asthma. Rodríguez-Martínez CE; Sossa-Briceño MP; Castro-Rodriguez JA J Asthma; 2013 May; 50(4):410-8. PubMed ID: 23356720 [TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma. Sullivan SD; Buxton M; Andersson LF; Lamm CJ; Liljas B; Chen YZ; Pauwels RA; Weiss KB J Allergy Clin Immunol; 2003 Dec; 112(6):1229-36. PubMed ID: 14657888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]